The Food and Drug Administration is currently reviewing a first-of-its-kind, twice-yearly injectable medication that experts say could revolutionize HIV prevention. The drug, Lenacapavir, has shown ...

People living with HIV have a significantly increased risk of cardiovascular disease that requires a different level of ...

If you’re between 15 and 34 years old and living in Cebu City, you may be part of the age group most affected by a health ...